Aslı Kısım

419 total citations
17 papers, 339 citations indexed

About

Aslı Kısım is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Aslı Kısım has authored 17 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Plant Science. Recurrent topics in Aslı Kısım's work include Cell death mechanisms and regulation (4 papers), Research in Cotton Cultivation (3 papers) and Bone health and treatments (3 papers). Aslı Kısım is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Research in Cotton Cultivation (3 papers) and Bone health and treatments (3 papers). Aslı Kısım collaborates with scholars based in Türkiye, United States and Albania. Aslı Kısım's co-authors include Rüçhan Uslu, Burçak Karaca, Harika Atmaca, Selim Uzunoğlu, Sibel Eyigör, Bülent Karabulut, Canfeza Sezgin, Emir Bozkurt, Devrim Pesen‐Okvur and Burcu Çakar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Urology.

In The Last Decade

Aslı Kısım

17 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aslı Kısım Türkiye 10 133 132 47 42 38 17 339
Anisha Kothari United States 6 88 0.7× 262 2.0× 46 1.0× 25 0.6× 25 0.7× 9 465
Alireza Khooei Iran 10 139 1.0× 112 0.8× 12 0.3× 37 0.9× 29 0.8× 38 425
Mohamad Assi France 10 97 0.7× 192 1.5× 69 1.5× 35 0.8× 14 0.4× 21 381
Shihui Bao China 10 47 0.4× 142 1.1× 43 0.9× 41 1.0× 17 0.4× 17 379
Wenquan Liang China 11 58 0.4× 109 0.8× 16 0.3× 62 1.5× 14 0.4× 41 348
Yiming Fu China 11 65 0.5× 138 1.0× 37 0.8× 26 0.6× 7 0.2× 34 338
Shufang Huang China 9 41 0.3× 128 1.0× 50 1.1× 23 0.5× 21 0.6× 27 300
Jiajia Ma China 11 39 0.3× 195 1.5× 61 1.3× 14 0.3× 17 0.4× 20 333
Lulu Wang China 13 49 0.4× 218 1.7× 111 2.4× 29 0.7× 10 0.3× 26 458
Francisco Chung United States 10 124 0.9× 123 0.9× 18 0.4× 12 0.3× 58 1.5× 13 345

Countries citing papers authored by Aslı Kısım

Since Specialization
Citations

This map shows the geographic impact of Aslı Kısım's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aslı Kısım with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aslı Kısım more than expected).

Fields of papers citing papers by Aslı Kısım

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aslı Kısım. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aslı Kısım. The network helps show where Aslı Kısım may publish in the future.

Co-authorship network of co-authors of Aslı Kısım

This figure shows the co-authorship network connecting the top 25 collaborators of Aslı Kısım. A scholar is included among the top collaborators of Aslı Kısım based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aslı Kısım. Aslı Kısım is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kısım, Aslı, et al.. (2023). FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. Communications Biology. 6(1). 199–199. 11 indexed citations
2.
Dogan, Elvan, et al.. (2021). Cancer Stem Cells in Tumor Modeling: Challenges and Future Directions. SHILAP Revista de lepidopterología. 1(11). 15 indexed citations
3.
Dogan, Elvan, et al.. (2021). Cancer Stem Cells in Tumor Modeling: Challenges and Future Directions. Advanced NanoBiomed Research. 1(11). 6 indexed citations
4.
Yürekli, Banu Şarer, Burçak Karaca, Aslı Kısım, et al.. (2017). AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells. Journal of Endocrinological Investigation. 41(2). 233–240. 6 indexed citations
5.
Atmaca, Harika, Emir Bozkurt, Aslı Kısım, & Rüçhan Uslu. (2016). Comparative analysis of XTT assay and xCELLigence system by measuring cytotoxicity of resveratrol in human cancer cell lines. Turkish Journal of Biochemistry. 41(6). 413–421. 9 indexed citations
6.
Varol, Umut, Burçak Karaca, Harika Atmaca, et al.. (2014). Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines. Tumor Biology. 36(2). 779–786. 4 indexed citations
7.
Çakar, Burcu, Harika Atmaca, Aslı Kısım, et al.. (2013). Paclitaxel in combination with AT-101 induces apoptosis via supressing Bcl-2, bcl-XL, mcl-1 proteins in human breast cancer cells.. Journal of Clinical Oncology. 31(15_suppl). e13578–e13578. 1 indexed citations
8.
Eyigör, Sibel, et al.. (2013). Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients. European Journal of Cancer Care. 22(5). 626–637. 95 indexed citations
9.
Bozkurt, Emir, Harika Atmaca, Aslı Kısım, et al.. (2012). Effects ofThymus serpyllumExtract on Cell Proliferation, Apoptosis and Epigenetic Events in Human Breast Cancer Cells. Nutrition and Cancer. 64(8). 1245–1250. 41 indexed citations
10.
Kısım, Aslı, Harika Atmaca, Burcu Çakar, et al.. (2012). Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. Journal of Cancer Research and Clinical Oncology. 138(7). 1155–1163. 21 indexed citations
11.
12.
Karaca, Burçak, Harika Atmaca, Emir Bozkurt, et al.. (2012). Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells. Molecular Biology Reports. 40(6). 3925–3933. 37 indexed citations
13.
Kısım, Aslı & Selim Uzunoğlu. (2012). HORMESIS: Antecedent phenomena for adaptation to low doses of toxic agents. 26(3). 180–190. 2 indexed citations
14.
Uzunoğlu, Selim, Burçak Karaca, Harika Atmaca, et al.. (2011). Targeting Bcl-2 Protein to Enhance Chemosensitivity of Hormone Refractory Prostate Cancer Cell Line, DU-145 by a Synergistic Combination of Docetaxel and Gossypol. Turkiye Klinikleri Journal of Medical Sciences. 31(4). 859–866. 1 indexed citations
15.
Uzunoğlu, Selim, Burçak Karaca, Harika Atmaca, et al.. (2010). Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (−/− gossypol). Toxicology Mechanisms and Methods. 20(8). 482–486. 38 indexed citations
16.
Karabulut, Bülent, Burçak Karaca, Umut Varol, et al.. (2010). Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer. Journal of Experimental & Clinical Cancer Research. 29(1). 102–102. 21 indexed citations
17.
Karabulut, Bülent, Burçak Karaca, Harika Atmaca, et al.. (2010). Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines. Molecular Biology Reports. 38(1). 249–259. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anisha Kothari Breakdown of academic impact, for papers by Alireza Khooei Breakdown of academic impact, for papers by Mohamad Assi Breakdown of academic impact, for papers by Shihui Bao Breakdown of academic impact, for papers by Wenquan Liang Breakdown of academic impact, for papers by Yiming Fu Breakdown of academic impact, for papers by Shufang Huang Breakdown of academic impact, for papers by Jiajia Ma Breakdown of academic impact, for papers by Lulu Wang Breakdown of academic impact, for papers by Francisco Chung
Rankless by CCL
2026